A Clinical Trial of BGT-002 Tablets in Subjects With Nonalcoholic Steatohepatitis
Clinical trial NCT06491576 · COMPLETED
Trial details
- NCT number
- NCT06491576
- Sponsor
- Burgeon Therapeutics Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-21
- Primary completion
- 2024-03-04
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.